High rates of flares after anti‐tumor necrosis factor withdrawal in pediatric inflammatory bowel disease: A multi‐center study
OBJECTIVES: Outcomes of anti-tumor necrosis factor (anti-TNF) discontinuation in pediatric patients with inflammatory bowel disease (IBD) remain unclear. We aimed to quantify relapse and biologic re-initiation rates following anti-TNF withdrawal in patients in sustained clinical remission for at least 6 months. METHODS: Patients' characteristics were recorded at the time of anti-TNF discontinuation, at the time of flare, or at the end of follow-up, with a minimum follow-up of 1 year. A flare was defined as clinical, biochemical, or endoscopic activity leading to hospitalization, systemic corticosteroids, and/or initiation of a biologic. RESULTS: This multicenter retrospective study from the Pediatric IBD Porto Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) included 83 children from 21 centers (46 [55%] males, 59 Crohn's disease [CD], 24 ulcerative colitis [UC]), who discontinued anti-TNF. At the time of anti-TNF withdrawal, the median age was 14.8 years (interquartile range 12.4-16.9); 93% had biochemical remission, and 68% of those undergoing endoscopy were in endoscopic remission. Within 12 and 24 months, 45/83 (54%) and 56/74 (76%) experienced a flare, and 29/83 (35%) and 47/68 (69%) re-initiated a biologic, respectively. Overall, flare and biologic re-initiation rates were similar in CD and UC, between those with biochemical or endoscopic remission, and among those maintained on immunomodulators (n = 33) or 5-aminosalicylates (n = 20). Univariate and multivariable Cox models did not identify baseline predictors of relapse or biologic re-initiation. CONCLUSIONS: Discontinuing anti-TNF therapy in pediatric IBD patients in clinical remission is associated with high rates of disease flare and treatment re-initiation. This provides quantitative data to help balance the benefits and risks when considering anti-TNF withdrawal.
Authors
- Ben Kang (ORCID: https://orcid.org/0000-0002-8516-9803)
- Patrizia Alvisi (ORCID: https://orcid.org/0000-0003-2770-1379)
- Caterina Strisciuglio (ORCID: https://orcid.org/0000-0002-9005-6571)
- Karl Mårild (ORCID: https://orcid.org/0000-0003-2285-8713)
- Paulina Krawiec (ORCID: https://orcid.org/0000-0002-2197-2197)
- Ramit Magen‐Rimon (ORCID: https://orcid.org/0000-0002-3701-660X)
- Jarosław Kierkuś (ORCID: https://orcid.org/0000-0003-2272-1581)
- Iva Hojsak (ORCID: https://orcid.org/0000-0003-3262-5964)
- Helena J. Rolandsdotter (ORCID: https://orcid.org/0000-0002-5453-6754)
- Kaija‐Leena Kolho (ORCID: https://orcid.org/0000-0001-9170-8415)
- Maya Granot (ORCID: https://orcid.org/0000-0002-1553-5847)
- Laura Gianolio (ORCID: https://orcid.org/0009-0003-1189-9373)
- Firas Rinawi (ORCID: https://orcid.org/0000-0001-7634-5310)
- Richard Kay Russell (ORCID: https://orcid.org/0000-0001-7398-4926)
- Saverio Pochesci (ORCID: https://orcid.org/0009-0000-6357-9273)
- Anat Yerushalmy‐Feler (ORCID: https://orcid.org/0000-0003-0200-6425)
- Lissy de Ridder (ORCID: https://orcid.org/0000-0002-6035-1182)
- Yael Haberman (ORCID: https://orcid.org/0000-0003-2680-1570)
- Assaf Hoofien (ORCID: https://orcid.org/0000-0001-5634-680X)
- Salvatore Oliva (ORCID: https://orcid.org/0000-0003-2348-2308)
- Bénédicte Pigneur (ORCID: https://orcid.org/0000-0002-5324-9964)
- Marta Velasco Rodríguez‐Belvís (ORCID: https://orcid.org/0000-0003-2844-313X)
- Dror S. Shouval (ORCID: https://orcid.org/0000-0001-5980-2954)
- Batia Weiss (ORCID: https://orcid.org/0000-0001-9894-6491)
- Anouk E Camman (ORCID: https://orcid.org/0009-0005-2846-4207)
Institutions
- Medical University of Lublin (PL)
- Cincinnati Children's Hospital Medical Center (US)
- Hôpital Necker-Enfants Malades (FR)
- University of Helsinki (FI)
- Tel Aviv University (IL)
- Technion – Israel Institute of Technology (IL)
- University of Zagreb (HR)
- University of Milan (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- Université Paris Cité (FR)
- Emek Medical Center (IL)
- Tel Aviv Sourasky Medical Center (IL)
- Sheba Medical Center (IL)
- Leiden University Medical Center (NL)
- Kaplan Medical Center (IL)
- Policlinico Umberto I (IT)
- Helsinki University Hospital (FI)
- Rambam Health Care Campus (IL)
- Erasmus MC (NL)
- Karolinska Institutet (SE)
- Kyungpook National University (KR)
- Helsinki Children's Hospital (FI)
- Stockholm South General Hospital (SE)
- Assistance Publique – Hôpitaux de Paris (FR)
- Ospedale Maggiore Carlo Alberto Pizzardi (IT)
- Schneider Children's Medical Center (IL)
- Hospital Infantil Universitario Niño Jesús (ES)
- Children's Memorial Health Institute (PL)
- Rappaport Family Institute for Research in the Medical Sciences (IL)
- Sachs' Children and Youth Hospital (SE)
- Willem-Alexander Kinderziekenhuis (NL)
- Children's Hospital Zagreb (HR)
- Ospedale dei Bambini Vittore Buzzi (IT)
- Erasmus MC - Sophia Children’s Hospital (NL)
- Edmond and Lily Safra Children's Hospital (IL)
- University of Cincinnati (US)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Journal of Pediatric Gastroenterology and Nutrition
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1002/jpn3.70680
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Leona M. and Harry B. Helmsley Charitable Trust
- Israel Science Foundation
- Tel Aviv University
- European Research Council